Skip to main content
Clinical Trials/KCT0000826
KCT0000826
Completed
未知

Overall Analysis of Clinical Factors for Prognosis in Bell’s Palsy

Kyung Hee University Hospital0 sites1,500 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the ear and mastoid process
Sponsor
Kyung Hee University Hospital
Enrollment
1500
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Observational Study
Sex
All

Investigators

Sponsor
Kyung Hee University Hospital

Eligibility Criteria

Inclusion Criteria

  • Bell’s palsy was diagnosed when there was no abnormality on brain MRI and internal acoustic canal (IAC) MRI scans and no other medical conditions causing facial palsy could be identified.

Exclusion Criteria

  • 1\. Tumor, Stroke and other conditions causing facial palsy in brain, internal auditory canal MRI
  • 2\. other medical conditions causing facial palsy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Analysis of Clinicopathological Factors and Prognosis for Gastrointestinal Cancer Treated with Endoscopic Surgery (including Robotic Surgery)gastrointestinal cancer
JPRN-UMIN000032895International University of Health and Welfare Hospital450
Recruiting
Phase 3
Determining factors of prognosis and morbidity in Chronic Chagas Heart Disease - phase III
RBR-9gm9bzniversidade Federal de Minas Gerais
Completed
Not Applicable
Analysis of risk factors and prognostic factors included histological status of underlying liver disease of patients undergoing curative resection or radiofrequency ablation of hepatocellular carcinoma; May hepatic steatosis correlate with the postoperative recurrence of hepatocellular carcinoma?Patients with Hepatocellular carcinoma(HCC) after curative treatment
JPRN-UMIN000000970Department of Internal Medicine, National Hospital Organization IwakuniClinical Center400
Completed
Not Applicable
Clinical Outcomes and Prognostic Factors to Predict Treatment Response in High Risk Neuroblastoma Patients Receiving Topotecan and Cyclophosphamide Containing Induction Regimen: A Prospective Multicenter StudyThe study is an observational study and aims to evaluate the clinical outcomes and classify relevant prognostic factors to measure induction response among high risk neuroblastoma patients in Thailandhigh risked neuroblastoma&#44topotecan&#44induction therapy&#44treatment response&#44prognostic factor&#44treatment&#45related toxicity
TCTR20190602002Phramongkutklao Hospital and College of Medicine107
Not yet recruiting
Not Applicable
Analysis for the prediction of systemic therapies in patients with locally advanced hepatocellular carcinomaNeoplasms
KCT0004206Seoul National University Hospital400